PharmTech LCGC Sciex Webinar 11.10
|Articles|May 27, 2005

Drug Shortage Resolved

Drug Shortage Resolved

Oxford Pharmaceutical's (Totowa, NJ) antidepressant drug “Marplan” (isocarboxazid, 10-mg dosage) has been removed from the US Food and Drug Administration’s list of drug shortages. Oxford resumed normal distribution of Marplan on May 27.

Marplan is a second-line treatment for depression offered as an option for patients who are unresponsive to other antidepressants such as selective serotonin reuptake inhibitors or traditional antidepressants such as amitriptyline.


Related to this article

AAPS PharmSci 360 2026: Roller-Compacted Formulations
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.